Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

[Predictors of mortality among liver transplant candidates].

Erez D, Ben Ari Z, Michowitz R, Mor E.

Harefuah. 2011 Jan;150(1):16-20, 70, 69. Hebrew.

PMID:
21449150
2.

Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.

Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R.

Isr Med Assoc J. 2006 Sep;8(9):605-9.

3.

Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.

Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.

Transplant Proc. 2012 Oct;44(8):2283-5. doi: 10.1016/j.transproceed.2012.07.045.

PMID:
23026574
4.

Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas.

Molinari M, Renfrew PD, Petrie NM, De Coutere S, Abdolell M.

Transpl Int. 2011 Mar;24(3):292-9. doi: 10.1111/j.1432-2277.2010.01200.x. Epub 2010 Dec 10.

5.

Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?

Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA.

Transpl Int. 2006 Apr;19(4):275-81.

6.

Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.

Gheorghe L, Popescu I, Iacob R, Iacob S, Gheorghe C.

Transpl Int. 2005 May;18(5):572-6.

7.

The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.

Salvalaggio P, Afonso RC, Pereira LA, Ferraz-Neto BH.

Einstein (Sao Paulo). 2012 Jul-Sep;10(3):278-85. English, Portuguese.

8.

Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.

Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y.

J Gastroenterol. 2014 Feb;49(2):324-31. doi: 10.1007/s00535-013-0782-5. Epub 2013 Mar 12.

PMID:
23478939
9.

The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.

Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM.

Am J Transplant. 2008 Feb;8(2):419-25. doi: 10.1111/j.1600-6143.2007.02086.x. Epub 2008 Jan 7.

10.

Mortality while awaiting liver retransplantation: predictability of MELD scores.

Watt KD, Menke T, Lyden E, McCashland TM.

Transplant Proc. 2005 Jun;37(5):2172-3.

PMID:
15964370
11.

Does model for end-stage liver disease (MELD) require modification?

Desai HG.

J Assoc Physicians India. 2011 Jun;59:372-3.

PMID:
21751591
12.

Deaths on the liver transplant waiting list: an analysis of competing risks.

Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER.

Hepatology. 2006 Feb;43(2):345-51.

PMID:
16440361
13.

Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?

Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.

Arch Surg. 2007 Nov;142(11):1079-85.

PMID:
18025337
14.

Current status and future of liver transplantation.

Merion RM.

Semin Liver Dis. 2010 Nov;30(4):411-21. doi: 10.1055/s-0030-1267541. Epub 2010 Oct 19. Review.

PMID:
20960380
15.

Model for end-stage liver disease (MELD) and allocation of donor livers.

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R; United Network for Organ Sharing Liver Disease Severity Score Committee.

Gastroenterology. 2003 Jan;124(1):91-6.

PMID:
12512033
16.

End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.

Sharma P, Schaubel DE, Gong Q, Guidinger M, Merion RM.

Hepatology. 2012 Jan;55(1):192-8. doi: 10.1002/hep.24632. Epub 2011 Nov 15. Erratum in: Hepatology. 2012 Apr;55(4):1311.

17.

Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P.

BMC Gastroenterol. 2009 Sep 25;9:72. doi: 10.1186/1471-230X-9-72.

18.

Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 year.

Lee YM, Wai CT, Da Costa M, Lee KH, Sutedja D, Tan KC, Isaac J, Lim SG.

Transplant Proc. 2005 Dec;37(10):4365-6.

PMID:
16387121
19.

Risk factors for long-term mortality in a large cohort of patients wait-listed for liver transplantation in Brazil.

Basto ST, Villela-Nogueira CA, Tura BR, Coelho HS, Ribeiro J, Fernandes ES, Schmal AF, Victor L, Luiz RR, Perez RM.

Liver Transpl. 2011 Sep;17(9):1013-20. doi: 10.1002/lt.22344.

20.

Use of MELD score in country with low organ donation.

Limsrichamrern S, Mahawithitwong P, Sirivatanauksorn Y, Mitmanochai P.

J Med Assoc Thai. 2013 Aug;96(8):924-8.

PMID:
23991598
Items per page

Supplemental Content

Write to the Help Desk